Collaboration in Origin´s open platform and presentation of novel 3D Printing material solutions for the medical sector at MDM West
To further drive the adoption of 3D Printing technologies beyond prototyping to final parts production Henkel has joined Origin´s open materials platform. The companies have signed an agreement to combine Henkel´s materials expertise with Origin´s printer and software know-how. The partnership has already resulted in novel 3D Printing solutions for the medical sector which will be showcased during the upcoming MDM West event.
Henkel aims to further drive additive manufacturing towards the mass production of functional parts across various industries. The company launched a differentiated platform of next-generation resins during the Formnext in November 2018. By joining Origin´s open materials platform Henkel will further intensify the development of customized materials for 3D Printing solutions of final parts.
“Our engineering resins respond to some of the most severe limitations for additive manufacturing at scale,” explained Philipp Loosen, Head of 3D Printing at Henkel. “We have determined that Origin´s novel programmable photopolymerization technology (P3) offers a complementary technology for our high-performance materials. The partnership has a huge potential to enable a wide range of our resin portfolio for use in additive mass production, especially in the health and wellness sector.”
Henkel and Origin will showcase some of their novel silicone-based 3D printed parts during this year´s leading medical design and manufacturing trade show (MDM West) from February 5th to 7th in Anaheim, CA. The parent silicone resins have been tested to Henkel’s protocols based upon ISO-10993 biocompatibility standards. The potential applications range from medical devices and surgery tools to pre-surgical models, hearing aids, face masks, and others